Here’s why Greater Cincinnati firm Airway Therapeutics just raised $6.3M

Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Airway Therapeutics, a Sharonville biotechnology company, has raised $6.3 million in bridge financing from new and existing investors to help develop a way to prevent and treat lung disease in premature babies.

The firm is developing a protein replacement therapy called AT-100, which is based on research conducted by Dr. Jeffrey Whitset at Cincinnati Children’s Hospital Medical Center.

Click here to read the complete article.

Originally published March 7, 2017.